Published by Frank Prenesti on 19th December 2022
(Sharecast News) - AstraZeneca's Forxiga drug has been recommended for approval in the EU for symptomatic chronic heart failure, the pharma company said on Monday.
URL: http://www.digitallook.com/dl/news/story/33186419/...